Toll-like receptor, RIG-I-like receptors and the NLRP3 inflammasome: key modulators of innate immune responses to double-stranded RNA viruses
- PMID: 21466970
- PMCID: PMC3109132
- DOI: 10.1016/j.cytogfr.2011.02.001
Toll-like receptor, RIG-I-like receptors and the NLRP3 inflammasome: key modulators of innate immune responses to double-stranded RNA viruses
Abstract
Double-stranded RNA (dsRNA), the genetic material for many RNA viruses, induces robust host immune responses via pattern recognition receptors, which include Toll-like receptor 3 (TLR3), retinoic acid-inducible gene-I-like receptors (RLRs) and the multi-protein NLRP3 inflammasome complex. The engagement of dsRNA receptors or inflammasome activation by viral dsRNA initiates complex intracellular signaling cascades that play essential roles in inflammation and innate immune responses, as well as the resultant development of adaptive immunity. This review focuses on signaling pathways mediated by TLR3, RLRs and the NLRP3 inflammasome, as well as the potential use of agonists and antagonists that target these pathways to treat disease.
Published by Elsevier Ltd.
Figures



Similar articles
-
Cytosolic double-stranded RNA activates the NLRP3 inflammasome via MAVS-induced membrane permeabilization and K+ efflux.J Immunol. 2014 Oct 15;193(8):4214-4222. doi: 10.4049/jimmunol.1400582. Epub 2014 Sep 15. J Immunol. 2014. PMID: 25225670 Free PMC article.
-
Double-stranded RNA induces an antiviral defense status in epidermal keratinocytes through TLR3-, PKR-, and MDA5/RIG-I-mediated differential signaling.J Immunol. 2008 Aug 15;181(4):2694-704. doi: 10.4049/jimmunol.181.4.2694. J Immunol. 2008. PMID: 18684960
-
Mechanisms and pathways of innate immune activation and regulation in health and cancer.Hum Vaccin Immunother. 2014;10(11):3270-85. doi: 10.4161/21645515.2014.979640. Hum Vaccin Immunother. 2014. PMID: 25625930 Free PMC article. Review.
-
The DHX33 RNA helicase senses cytosolic RNA and activates the NLRP3 inflammasome.Immunity. 2013 Jul 25;39(1):123-35. doi: 10.1016/j.immuni.2013.07.001. Epub 2013 Jul 18. Immunity. 2013. PMID: 23871209 Free PMC article.
-
[Recent progress of the mechanisms for RNA viruses to block the recognition of dsRNA with RIG-I-like receptors].Bing Du Xue Bao. 2014 Nov;30(6):704-12. Bing Du Xue Bao. 2014. PMID: 25868287 Review. Chinese.
Cited by
-
HLA-B35 and dsRNA induce endothelin-1 via activation of ATF4 in human microvascular endothelial cells.PLoS One. 2013;8(2):e56123. doi: 10.1371/journal.pone.0056123. Epub 2013 Feb 18. PLoS One. 2013. Retraction in: PLoS One. 2020 Oct 22;15(10):e0241404. doi: 10.1371/journal.pone.0241404. PMID: 23441162 Free PMC article. Retracted.
-
Identification of Secreted Proteins Involved in Nonspecific dsRNA-Mediated Lutzomyia longipalpis LL5 Cell Antiviral Response.Viruses. 2018 Jan 18;10(1):43. doi: 10.3390/v10010043. Viruses. 2018. PMID: 29346269 Free PMC article.
-
Prdx6 Regulates Nlrp3 Inflammasome Activation-Driven Inflammatory Response in Lens Epithelial Cells.Int J Mol Sci. 2023 Nov 13;24(22):16276. doi: 10.3390/ijms242216276. Int J Mol Sci. 2023. PMID: 38003466 Free PMC article.
-
14-3-3ε and 14-3-3σ inhibit Toll-like receptor (TLR)-mediated proinflammatory cytokine induction.J Biol Chem. 2012 Nov 9;287(46):38665-79. doi: 10.1074/jbc.M112.367490. Epub 2012 Sep 14. J Biol Chem. 2012. Retraction in: J Biol Chem. 2014 Sep 12;289(37):25474. doi: 10.1074/jbc.A112.367490. PMID: 22984265 Free PMC article. Retracted.
-
Trial watch: TLR3 agonists in cancer therapy.Oncoimmunology. 2020 Jun 2;9(1):1771143. doi: 10.1080/2162402X.2020.1771143. Oncoimmunology. 2020. PMID: 32934877 Free PMC article. Review.
References
-
- Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4:499–511. - PubMed
-
- Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol. 2004;5:987–995. - PubMed
-
- Matsumoto M, Funami K, Tanabe M, et al. Subcellular localization of Toll-like receptor 3 in human dendritic cells. J Immunol. 2003;171:3154–3162. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources